XM does not provide services to residents of the United States of America.

Chips boost Japan's Nikkei, but caution ahead of key central bank meetings caps gains



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Chips boost Japan's Nikkei, but caution ahead of key central bank meetings caps gains</title></head><body>

By Brigid Riley

TOKYO, Dec 16 (Reuters) -Japan's Nikkei share average climbed on Monday as chip-related shares were boosted by a rise in their U.S. peers, but investors' positioning ahead of major central bank decisions this week capped gains.

The Nikkei .N225 added 0.2% to 39,533.55 by the midday break, while the broader Topix .TOPX shed 0.04% to 2,745.46.

While U.S. stocks closed the trading week near the unchanged mark in a subdued session on Friday, the Philadelphia SE Semiconductor Index .SOX surged 3.4%. .N

Japan's chip-related shares tracked their peers higher to boost the Nikkei, led by chip-testing equipment maker Advantest's 6857.T 1.9% rise.

Tokyo Electron 8035.T added 0.5% and Socionext 6526.T rallied 9.1% to become the top percentage gainer on the benchmark.

However, moves were restrained as market players awaited what is expected to be another 25-basis-points cut by the U.S. Federal Reserve on Wednesday, followed by the Bank of Japan's (BOJ) monetary policy decision on Thursday.

"There's certainly a strong sense that investors are taking a wait-and-see approach," said Hiroshi Namioka, chief strategist at T&D Asset Management.

Reuters and other media outlets reported that the BOJ is leaning toward keeping rates steady at their meeting this week.

The yen was last hovering around 153.88 per U.S. dollar JPY=EBS, struggling to recover from its worst week since September on the back of those media reports. FRX/

Isuzu Motors 7202.T, up 2%, was among exporter shares to gain on a softer yen, although caution weighed, with Toyota 7203.T rising only 0.1% and Mitsubishi Motor 7211.T sliding 1.1%.

Among other major shares, AI-focused startup investor SoftBank Group 9984.T advanced 0.5% and Chugai Pharmaceutical 4519.T climbed 2%.

Uniqlo brand owner Fast Retailing 9983.T stumbled 0.2%, while entertainment conglomerate Sony Group 6758.T slid 0.8%.



Reporting by Brigid Riley; Editing by Sumana Nandy

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.